martínez-cengotitabengoa, lars vedel kessing, andrea fagiolini, michael bauer, guy m. goodwin, ana gonzález-pinto, ralph kupka, thomas g. schulze, trine vik lagerberg, aysegul yildiz, chantal henry, gunnar morken, phillip ritter, rené ernst nieslen, rasmus wentzer licht, andreas bechdolf,...
“After several decades of little progress in the field, Adstiladrin brings a major innovation to patients with high-risk NMIBC who no longer respond to current first-line treatment and have few other good options. Our ambition is for Adstiladrin to become the new standard of care and the...
“After several decades of little progress in the field, Adstiladrin brings a major innovation to patients with high-risk NMIBC who no longer respond to current first-line treatment and have few other good options. Our ambition is for Adstiladrin to become the new standard of care and the...